By Toni Clarke WASHINGTON (Reuters) – The U.S. Food and Drug Administration recommended on Tuesday that blood should no longer be collected from regions where the Zika virus is circulating, and that blood needed for transfusions be obtained from areas of the country without active transmission. The agency said blood banks can continue collecting and preparing platelets and plasma if an FDA-approved pathogen-reduction technology is used. The guidelines come as Zika is spreading rapidly through the Americas, with more than 30 affected countries in Latin America and the Caribbean.
Read more:
FDA recommends ban on blood collections from Zika-affected areas
